Effect of Blueberries on Immunity
NCT05534893 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52
Last updated 2026-02-04
Summary
This research study will test the effects of Blueberries on immune functions in overweight older men and postmenopausal women
Conditions
- Immune Response
- Inflammation
Interventions
- DIETARY_SUPPLEMENT
-
Blueberry powder group
Participants in the blueberry powder group will receive freeze dried blueberries in form of a powder
- DIETARY_SUPPLEMENT
-
Placebo powder group
Participants in the placebo powder group will receive an isocaloric placebo powder
Sponsors & Collaborators
-
U.S. Highbush Blueberry Council
collaborator OTHER -
Loma Linda University
lead OTHER
Principal Investigators
-
Joan Sabate, DrPH · Loma Linda University
-
Sujatha Rajaram, PhD · Loma Linda University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-10-12
- Primary Completion
- 2023-09-12
- Completion
- 2023-09-12
Countries
- United States
Study Locations
More Related Trials
-
Effects of BCG on Influenza Induced Immune Response
NCT02114255 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Understanding Immunity to the Flu Vaccine in COVID-19 Patients
NCT04579588 ·Status: RECRUITING
-
Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in Adults
NCT00333398 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Antibody Response of Influenza Vaccination Following Concomitant Exposure to Bimekizumab in Healthy Subjects
NCT03895385 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza Vaccines
NCT00776438 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) [Ph.Eur], Formulation 2009-2010, When Administered to Non-Elderly Adult and Elderly Subjects
NCT00956449 ·Status: COMPLETED ·Phase: PHASE2
-
Influenza Vaccine Safety and Effectiveness in Healthcare Providers
NCT01282177 ·Status: COMPLETED
-
Immune Response Study of Influenza Vaccine
NCT01310374 ·Status: COMPLETED
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects
NCT00522236 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Immune Responses to Influenza Vaccination
NCT03346772 ·Status: RECRUITING ·Phase: PHASE4
-
Immune Response Analysis to Influenza Vaccine in Elderly Aged Over 65 Years
NCT01289535 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety, Reactogenicity, and Immunogenicity of Inactivated Influenza A/H7/N7 Vaccine in Healthy Adults
NCT00546585 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Mood and Influenza Vaccine Response: A Feasibility Trial
NCT03144518 ·Status: COMPLETED ·Phase: NA
-
Impact of High Dietary Fiber on Microbiome and Vaccine Responses
NCT05565586 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine
NCT05056519 ·Status: UNKNOWN ·Phase: PHASE1
-
Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intramuscular Route)
NCT01121822 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Three Licensed Influenza Vaccines
NCT03068949 ·Status: COMPLETED ·Phase: PHASE4
-
Protection From Influenza: Determining the Impact of Prior Infection
NCT03004040 ·Status: UNKNOWN
-
Safety Study of Freeze-dried Live Attenuated Influenza Vaccine for Intranasal Administration in Chinese Adults Aged 3 Years and Older
NCT02665871 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge
NCT02071329 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prospective Cohort Study to Evaluate Safety/Immunogenicity of Butantan Influenza Vaccine in Healthy Adults/Elderly
NCT02313740 ·Status: COMPLETED
-
Safety and Reactogenicity of FluBlok and Comparison of Immunogenicity, Efficacy and Effectiveness Against TIV
NCT00539864 ·Status: COMPLETED ·Phase: PHASE3
-
Persistence of Immune Response After Vaccination With Influenza Vaccine
NCT01906190 ·Status: COMPLETED ·Phase: NA
-
Revealing Protective Immunity to Influenza Using Systems Immunology
NCT06501963 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly
NCT00953524 ·Status: COMPLETED ·Phase: PHASE2